Newsworthy research stories, accomplishments, and spotlights from the department
Dane Sands and Xianya Qu Awarded the 2024-25 Zymeworks Fellowships
We are excited to extend our congratulations to Dane Sands and Xianya Qu, the 2024-25 recipients of the Zymeworks Fellowship in Advanced Protein Therapeutics.
Kronstad lab uncovering weaknesses for the fungal cause of cryptococcosis
Kronstad lab studies Cryptococcus neoformans, a deadly fungal pathogen in immunocompromised people. They've found key virulence factors and potential drug targets.
New Compound Shows Promise for Treating Tuberculosis
A new study from the Sun Lab (MBIM), co-led by PhD student Yichu Liang, presents SMIP-031, a novel compound enhancing immune response to treat tuberculosis (TB).
Jefferies lab demonstrates potential of a novel cell-based immunotherapy for cancer
A new study from the Jefferies lab (MSL, MedGen, MBIM, CBR) highlights a promising, novel avenue for cancer immunotherapy using Type 2 innate lymphoid cells.